ALIEN1 said:I'm on an off 5-HTP, just planning to buy another bottle. It's ver interesting, what you write about pot... Anyway, I feel 5-HTP helps me a lot, but I noticed that after longer time of taking it, it would not help me to feel sleepy anymore.
Mrs. Peel said:I currently take it right before bedtime, but I've tried taking it in the morning and afternoon also (with food). Problem is during the week when I'm at work, I've been falling asleep at my desk!
Supplement Vitamin B3 (niacin) to prevent breakdown of 5-HTP to niacinamide. Supplement Vitamin B6 and Magnesium to maximise benefits.
Nathan said:Mrs. Peel said:I currently take it right before bedtime, but I've tried taking it in the morning and afternoon also (with food). Problem is during the week when I'm at work, I've been falling asleep at my desk!
My 5-HTP bottle arrived today. There is a warning on the bottle that says "may cause sleepiness", so I don't know if taking it during the day is the best idea. Also, the New Zealand website I purchased from (you can't get 5-HTP in Australia) also recommended taking niacin as well. (healthy.co.nz)
Supplement Vitamin B3 (niacin) to prevent breakdown of 5-HTP to niacinamide. Supplement Vitamin B6 and Magnesium to maximise benefits.
cholas said:I too have just started taking HTP-5, 100mg per day and honestly don't notice any differences. Normally taken after meals and at various times during the day. Haven't really noticed any drowsiness either. Should I consider upping the dosage?
Laurentien said:I would like to know if I can take 5 htp while doing the mercury detox.
andi said:I have 5-htp at home and I took some but I have avoided to take it because I can see nothing written about gluten and since it says nothing, I suspect it contains gluten.
It says on the label - no diary, sugar, preservatives or starch (starch ?? does that imply a lack of gluten?). In all my other supplement it is written - no gluten. The brand is called ''Life'' , anybody has any idea?
You can take 5 HTP while doing the mercury detox, it will definitely help. The L-taurine is also a mood calmer and it is included in the protocol to "counteract" symptoms of mercury detox, also the melatonin.
Description
* Enhances Mood and Sleep Patterns
* Supports Weight Management
L-5-hydroxy-Tryptophan (5-HTP) is the immediate precursor of serotonin. The production and maintenance of serotonin levels in the brain are directly related to sleep patterns, mood shifts, tranquility, and compulsive behavior (including eating patterns). Use of 5-HTP has been shown to aid weight loss, reduce "carbo" cravings, improve mood and reduce mood fluctuations as well as promote normal sleep patterns.
* Natural Source from Griffonia Seed
* Tested for Potency and Purity
* Free of "Peek X" Contamination
Supplement Facts
Serving Size: 1 Vegetarian Tablets 1 Capsules
Servings per Container: 60
Amount Per Serving % Daily Value
L-5-Hydroxytryptophan (Griffonia simplicifolia seed) 100 mg *
*Daily value not established.
Other Ingredients: Rice Flour. Capsule is made of plant cellulose.
Free Of
Common allergens and artificial colors.
PTSD: The Serotonin System Influences Vulnerability And Treatment
Posted on: Friday, 18 June 2010, 00:45 CDT
There is a great deal of interest in factors that contribute to the vulnerability to developing post-traumatic stress disorder, or PTSD. One factor that appears to contribute to the heritable vulnerability to PTSD is a variation in the gene that codes for the serotonin transporter, also known as the serotonin uptake site. Having a shorter version of the serotonin transporter gene appears to increase one's risk for depression and PTSD after exposure to extremely stressful situations. This same gene variant increases the activation of an emotion control center in the brain, the amygdala. More recently, scientists began focusing on factors contributing to resilience to the impact of stress exposure. Could the same gene that contributes to the vulnerability to PTSD be implicated in the recovery from PTSD?
In their new study appearing in Biological Psychiatry, Dr. Richard Bryant and colleagues assessed whether serotonin transporter genotype predicted a change in patients' PTSD severity following treatment. Specifically, patients with PTSD were classified according to their genotype, and they received eight weeks of cognitive behavior therapy. Approximately one-third of patients do not respond to this treatment, and this study has now demonstrated that there may be a genetic basis for not responding to this therapy.
Dr. Bryant explained: "Patients with PTSD who carried the short allele of the serotonin transporter gene promoter responded more poorly to treatment than other PTSD patients. This study highlights that the serotonin system is implicated in responding to cognitive behavior therapy."
The recent focus on personalized medicine has emphasized the impact of variation in genes that influence the responses to medications. This study supports the reasoning that genetic variation would also influence the response to psychotherapeutic or rehabilitative treatments.
Dr. John Krystal, Editor of Biological Psychiatry, noted, "While this study identifies a potential predictor of poor treatment response, it also may help to identify groups of individuals who respond relatively favorably to treatment. It is interesting this 'good outcome' group is a group that is also more resilient, i.e., less likely to develop PTSD or depression, after stress."
Although further research is necessary, this initial finding indicates that PTSD treatments may need to be modified to accommodate patients' genetic profiles.